Literature DB >> 12610112

Induction of apoptosis by paramyxovirus simian virus 5 lacking a small hydrophobic gene.

Yuan Lin1, Angela C Bright, Terri A Rothermel, Biao He.   

Abstract

Simian virus 5 (SV5) is a member of the paramyxovirus family, which includes emerging viruses such as Hendra virus and Nipah virus as well as many important human and animal pathogens that have been known for years. SV5 encodes eight known viral proteins, including a small hydrophobic integral membrane protein (SH) of 44 amino acids. SV5 without the SH gene (rSV5deltaSH) is viable, and growth of rSV5deltaSH in tissue culture cells and viral protein and mRNA production in rSV5deltaSH-infected cells are indistinguishable from those of the wild-type SV5 virus. However, rSV5deltaSH causes increased cytopathic effect (CPE) and apoptosis in MDBK cells and is attenuated in vivo, suggesting the SH protein plays an important role in SV5 pathogenesis. How rSV5deltaSH induces apoptosis in infected cells has been examined in this report. Tumor necrosis factor alpha (TNF-alpha), a proinflammatory cytokine, was detected in culture media of rSV5deltaSH-infected cells. Apoptosis induced by rSV5deltaSH was inhibited by neutralizing antibodies against TNF-alpha and TNF-alpha receptor 1 (TNF-R1), suggesting that TNF-alpha played an essential role in rSV5deltaSH-induced apoptosis in a TNF-R1-dependent manner. Examination of important proteins in the TNF-alpha signaling pathway showed that p65, a major NF-kappaB subunit whose activation can lead to transcription of TNF-alpha, was first translocated to the nucleus and was capable of binding to DNA and then was targeted for degradation in rSV5deltaSH-infected cells while expression levels of TNF-R1 remained relatively constant. Thus, rSV5deltaSH induced cell death by activating TNF-alpha expression, possibly through activation of the NF-kappaB subunit p65 and then targeting p65 for degradation, leading to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610112      PMCID: PMC149502          DOI: 10.1128/jvi.77.6.3371-3383.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Activation of programmed cell death by recombinant human tumor necrosis factor plus topoisomerase II-targeted drugs in L929 tumor cells.

Authors:  N Kyprianou; R B Alexander; J T Isaacs
Journal:  J Natl Cancer Inst       Date:  1991-03-06       Impact factor: 13.506

2.  mRNA sequence and deduced amino acid sequence of the mumps virus small hydrophobic protein gene.

Authors:  N Elango; J Kövamees; T M Varsanyi; E Norrby
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  The 1A protein gene of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polycistronic transcript.

Authors:  P L Collins; G W Wertz
Journal:  Virology       Date:  1985-03       Impact factor: 3.616

4.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

5.  Sendai virus induces high levels of tumor necrosis factor mRNA in human peripheral blood leukocytes.

Authors:  S L Berent; R M Torczynski; A P Bollon
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

6.  Tumor necrosis factor induction by Sendai virus.

Authors:  D Aderka; H Holtmann; L Toker; T Hahn; D Wallach
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

7.  Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32).

Authors:  M Bitzer; F Prinz; M Bauer; M Spiegel; W J Neubert; M Gregor; K Schulze-Osthoff; U Lauer
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity.

Authors:  R M Lorence; P A Rood; K W Kelley
Journal:  J Natl Cancer Inst       Date:  1988-10-19       Impact factor: 13.506

9.  Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.

Authors:  B Beutler; D Greenwald; J D Hulmes; M Chang; Y C Pan; J Mathison; R Ulevitch; A Cerami
Journal:  Nature       Date:  1985 Aug 8-14       Impact factor: 49.962

10.  The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species.

Authors:  R A Olmsted; P L Collins
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

View more
  44 in total

1.  The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels.

Authors:  Siok-Wan Gan; Edward Tan; Xin Lin; Dejie Yu; Juejin Wang; Gregory Ming-Yeong Tan; Ardcharaporn Vararattanavech; Chiew Ying Yeo; Cin Huang Soon; Tuck Wah Soong; Konstantin Pervushin; Jaume Torres
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

2.  Characterization of Durham virus, a novel rhabdovirus that encodes both a C and SH protein.

Authors:  A B Allison; G Palacios; A Travassos da Rosa; V L Popov; L Lu; S Y Xiao; K DeToy; T Briese; W I Lipkin; M K Keel; D E Stallknecht; G R Bishop; R B Tesh
Journal:  Virus Res       Date:  2010-09-21       Impact factor: 3.303

3.  Characterization of the Tupaia rhabdovirus genome reveals a long open reading frame overlapping with P and a novel gene encoding a small hydrophobic protein.

Authors:  Christoph Springfeld; Gholamreza Darai; Roberto Cattaneo
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Abortive versus productive viral infection of dendritic cells with a paramyxovirus results in differential upregulation of select costimulatory molecules.

Authors:  Sharmila S Pejawar; Griffith D Parks; Martha A Alexander-Miller
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Function of small hydrophobic proteins of paramyxovirus.

Authors:  Rebecca L Wilson; Sandra M Fuentes; Ping Wang; Erica C Taddeo; Alicia Klatt; Andrew J Henderson; Biao He
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge.

Authors:  S Mark Tompkins; Yuan Lin; George P Leser; Kari A Kramer; Debra L Haas; Elizabeth W Howerth; Jie Xu; Mary J Kennett; Russell K Durbin; Joan E Durbin; Ralph Tripp; Robert A Lamb; Biao He
Journal:  Virology       Date:  2007-01-23       Impact factor: 3.616

7.  Immunogenicity of novel mumps vaccine candidates generated by genetic modification.

Authors:  Pei Xu; Zhenhai Chen; Shannon Phan; Adrian Pickar; Biao He
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

8.  Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus.

Authors:  Pei Xu; Zhuo Li; Dengyun Sun; Yuan Lin; Jianguo Wu; Paul A Rota; Biao He
Journal:  Virology       Date:  2011-06-14       Impact factor: 3.616

9.  Analysis of host- and strain-dependent cell death responses during infectious salmon anemia virus infection in vitro.

Authors:  Berit L Schiøtz; Espen S Baekkevold; Lene C Poulsen; Siri Mjaaland; Tor Gjøen
Journal:  Virol J       Date:  2009-07-01       Impact factor: 4.099

10.  PLK1 down-regulates parainfluenza virus 5 gene expression.

Authors:  Dengyun Sun; Priya Luthra; Zhuo Li; Biao He
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.